Purdue Pharma L.P. Statement on FDA Approval of New Label for Reformulated Oxycontin Tablets CII and Citizen Petition Regarding Withdrawal of Original Formulation Due to Safety April 16, 2013 - STAMFORD, Conn.
http://www.biospace.com/news_story.aspx?StoryID=293860&full=1
http://www.biospace.com/news_story.aspx?StoryID=293860&full=1
No comments:
Post a Comment